Technical Data
M2750-18B1
MCP4, Recombinant, Human (Macrophage/Monocyte Chemotactic Protein 4)
2ug
10ug
10ug
|
Technical Data |
|
M2750-18B1 |
MCP4, Recombinant, Human (Macrophage/Monocyte Chemotactic Protein 4) |
2ug 10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: RT |
|
Recombinant Human MCP-4 is a non-glycosylated, Polypeptide chain containing 74 amino acids and having a molecular mass of 8510 Dalton. Sequence: The sequence of the first five N-terminal amino acids was determined and was found to be Gln-Pro-Asp-Ala-Leu. Dimers and Aggregates: 1% as determined by silver-stained SDS-PAGE gel analysis. Biological Activity: MCP-4 is fully biologically active when compared to standard. The specific activity as determined by the ability of MCP-4 to chemoattaract human monocytes at 10-100ng/ml. Endotoxin: 0.1ng/ug (IEU/ug) of Human Monocyte Chemotactic Protein-4. Protein Content: Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280nm. 2. Analysis by RP-HPLC, using a calibrated solution of Human MCP-4 as a Reference Standard. Reconstitution: Reconstitute the lyophilized MCP-4 in sterile 18MO-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile dH2O and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: E. coli Purity: 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified. Form: Supplied as a lyophilized powder. No additives. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Monocyte chemotactic protein-4 (MCP-4; CCL-13): a biomarker of asthma. Kalayci O, Sonna LA, Camargo CA Jr, J Asthma 2004 Feb;41(1):27-33 2. Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells. Meyer-Hoffert U, Lezcano-Meza D, Montes-Vizuet AR, Int Arch Allergy Immunol 2003 Aug;131(4):264-71 3. IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells. Nakamura H, Luster AD, Jedrzkiewicz S, Yamaguchi K, Am J Physiol Lung Cell Mol Physiol 2001 Nov;281(5):L1288-302 4. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. Chakravorty SJ, Howie AJ, Gentle D, J Pathol 2001 Jun;194(2):239-46 5. Cloning of equine chemokines eotaxin, monocyte chemoattractant protein (MCP)-1, MCP-2 and MCP-4, mRNA expression in tissues and induction by IL-4 in dermal fibroblasts. Benarafa C, Cunningham FM, Horohov DW, Vet Immunol Immunopathol 2000 Oct 31;76(3-4):283-98 6. Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Lamkhioued B, Garcia-Zepeda EA, Nakamura H, Allakhverdi Z, Am J Respir Crit Care Med 2000 Aug;162(2 Pt 1):723-32.
|
||